Zobrazeno 1 - 10
of 53
pro vyhledávání: '"D, Faleo"'
Autor:
Nimish Vakil, R. Potì, Luigi Gatta, Cesare Hassan, F. Fornari, C. Papadia, M. Miglioli, A. Savioli, Antonio Merla, Francesco Perri, S. Morini, S. Campo, V. Rinaldi, D. Faleo, Claudio Ricci, Dino Vaira, Enzo Ierardi, S. Pilati, F. Perna, L. S. Mete, Angelo Zullo, V. De Francesco, G. Marinone, A. Tampieri, M Menegatti
Publikováno v:
Alimentary Pharmacology & Therapeutics. 17:719-726
Summary Background : Eradication rates of Helicobacter pylori with standard triple therapy are disappointing, and studies from several countries confirm this poor performance. Aim : To assess the eradication rate of a new sequential treatment regimen
Autor:
Marcella Margiotta, Ruggiero Francavilla, V. De Francesco, M. Gentile, S. Marangi, Nicola Muscatiello, Enzo Ierardi, Carmine Panella, Michele Barone, D. Faleo, Antonio Francavilla, Maurizio Cosimo Nacchiero, R. Cuomo
Publikováno v:
Alimentary Pharmacology & Therapeutics. 17:473-477
Summary Background : Recently, biliary sludge has been strongly correlated with ‘idiopathic pancreatitis’. It is often diagnosed by trans-abdominal ultrasonography, despite the low sensitivity of this investigation. New scanners, using second har
Publikováno v:
Digestive and Liver Disease. 33:676-679
Several studies have found a fairly low Helicobacter pylori eradication rate using a standard 7-day triple therapy in Italy. Recently, two new therapeutic schedules have been proposed with an eradication rate higher than 90%. This study compared the
Autor:
S. Winn, Cesare Hassan, Angelo Zullo, V. De Francesco, V. Stoppino, Adolfo Francesco Attili, V. Rinaldi, D. Faleo
Publikováno v:
Alimentary Pharmacology & Therapeutics. 13:163-168
Background: It has been suggested that short-term triple therapy comprising a proton pump inhibitor, plus clarithromycin and amoxycillin be used as first choice in treating H. pylori infection, while eradication failure patients should be further tre
Autor:
E, Ierardi, N, Muscatiello, M, Nacchiero, M, Gentile, M, Margiotta, S, Marangi, V, De Francesco, R, Francavilla, M, Barone, D, Faleo, C, Panella, A, Francavilla, R, Cuomo
Publikováno v:
Alimentary pharmacologytherapeutics. 17(3)
Recently, biliary sludge has been strongly correlated with 'idiopathic pancreatitis'. It is often diagnosed by trans-abdominal ultrasonography, despite the low sensitivity of this investigation. New scanners, using second harmonic imaging, may improv
Autor:
Antonio Francavilla, M.F. Minenna, Carmine Panella, R. Cuomo, Rosa Monno, Enzo Ierardi, Marcella Margiotta, O. Burattini, Vincenzo De Francesco, D. Faleo
Publikováno v:
Journal of clinical gastroenterology. 35(5)
Stool antigen test for Helicobacter pylori, a noninvasive assay, is emerging as a strong competitor to urea breath test (UBT). Nevertheless, although the UBT delta value is a semiquantitative indicator of H. pylori intragastric load, until now the H.
Publikováno v:
Il Giornale di chirurgia. 22(3)
HCC is a tumor with increasing incidence that usually develops on cirrhotic liver; therefore the prognosis depends on both tumor size and liver function. HCC generally shows a slow growth and (not very important) symptoms; so, the periodic surveillan
Publikováno v:
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver. 32(8)
Autor:
A, Ascione, M, De Luca, C, Canestrini, G G, Di Costanzo, G, Raimondo, G, Longo, M P, Manns, H L, Tillmann, G B, Forte, P, Rocco, O, Biceglia, D, Faleo, F, Vinelli, E M, Cela, L, Amitrano, L, Addario, T, Gigliotti
Publikováno v:
Italian journal of gastroenterology and hepatology. 30(5)
The long-term response to alpha-Interferon in HCV-related chronic liver diseases is disappointing. A randomized controlled trial was conducted to investigate: 1) if doubling the standard regimen of 3 MU recombinant alpha 2b-interferon thrice weekly f
Publikováno v:
The American Journal of Gastroenterology. 97:2686-2687
Sequential eradicating therapy: a treatment that does not discriminate Helicobacter pylori strains in patients with nonulcer dyspepsia?